Multi-Variate Approach to Global Protein Aggregation Behavior and Kinetics: Effects of pH, NaCl, and Temperature for α-Chymotrypsinogen A

被引:80
作者
Li, Yi [1 ]
Ogunnaike, Babatunde A. [1 ]
Roberts, Christopher I. [1 ]
机构
[1] Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA
基金
美国国家卫生研究院;
关键词
protein aggregation; stability; protein formulation; 2ND VIRIAL-COEFFICIENT; INTERLEUKIN-1 RECEPTOR ANTAGONIST; COLONY-STIMULATING FACTOR; HIGH-CONCENTRATION FORMULATIONS; NUCLEATED-POLYMERIZATION MODEL; CONFORMATIONAL STABILITY; IRREVERSIBLE AGGREGATION; PEPTIDE AGGREGATION; ACTIVATION-ENERGIES; AQUEOUS-SOLUTION;
D O I
10.1002/jps.21869
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A global characterization of normative aggregation is presented for (x-chymotrypsinogen A (aCgn) as a function of temperature (T), pH, and [NaCl]. Changes in unfolding free energy, native-state second osmotic virial coefficient (B-22), and aggregation pathways and kinetics were qualitatively and quantitatively determined using a combination of size-exclusion chromatography, multi-angle laser light scattering, and circular dichroism and fluorescence spectroscopy. Results were analyzed quantitatively using multi-variate statistical models and a recently developed mechanistic model that naturally accounts for changes in aggregation pathway due to competition between unfolding, nucleation, chain polymerization, aggregate condensation, and phase separation. State diagrams are presented that show the natural progression between different aggregation behaviors or pathways. Together, the results show that pH and [NaCl] determine both the rates of aggregation and what aggregation behavior or pathway holds. In contrast, T affects primarily only aggregation rates, in large part due to changes in unfolding free energy. Finally, it is shown that B22 correlates strongly with which type of aggregation pathway is followed, suggesting a potentially useful approach for predicting and controlling physical properties of the resulting aggregates. 0 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:645-662, 2010
引用
收藏
页码:645 / 662
页数:18
相关论文
共 69 条
  • [1] High concentration formulations of recombinant human interleukin-1 receptor antagonist: I. Physical characterization
    Alford, John R.
    Kwok, Stanley C.
    Roberts, Jennifer N.
    Wuttke, Deborah S.
    Kendrick, Brent S.
    Carpenter, John F.
    Randolph, Theodore W.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (08) : 3035 - 3050
  • [2] High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics
    Alford, John R.
    Kendrick, Brent S.
    Carpenter, John F.
    Randolph, Theodore W.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (08) : 3005 - 3021
  • [3] Nucleation, growth, and activation energies for seeded and unseeded aggregation of α-chymotrypsinogen A
    Andrews, Jennifer M.
    Weiss, William F.
    Roberts, Christopher J.
    [J]. BIOCHEMISTRY, 2008, 47 (08) : 2397 - 2403
  • [4] A Lumry-Eyring nucleated polymerization model of protein aggregation kinetics: 1. Aggregation with pre-equilibrated unfolding
    Andrews, Jennifer M.
    Roberts, Christopher J.
    [J]. JOURNAL OF PHYSICAL CHEMISTRY B, 2007, 111 (27) : 7897 - 7913
  • [5] Non-native aggregation of α-chymotrypsinogen occurs through nucleation and growth with competing nucleus sizes and negative activation energies
    Andrews, Jennifer M.
    Roberts, Christopher J.
    [J]. BIOCHEMISTRY, 2007, 46 (25) : 7558 - 7571
  • [6] ANDREWS JM, 2008, THESIS U DELAWARE NE, P318
  • [7] Protein structural conformation and not second virial coefficient relates to long-term irreversible aggregation of a monoclonal antibody and ovalbumin in solution
    Bajaj, Harminder
    Sharma, Vikas K.
    Badkar, Advait
    Zeng, David
    Nema, Sandeep
    Kalonia, Devendra S.
    [J]. PHARMACEUTICAL RESEARCH, 2006, 23 (06) : 1382 - 1394
  • [8] How Hofmeister ion interactions affect protein stability
    Baldwin, RL
    [J]. BIOPHYSICAL JOURNAL, 1996, 71 (04) : 2056 - 2063
  • [9] Aggregation of recombinant bovine granulocyte colony stimulating factor in solution
    Bartkowski, R
    Kitchel, R
    Peckham, N
    Margulis, L
    [J]. JOURNAL OF PROTEIN CHEMISTRY, 2002, 21 (03): : 137 - 143
  • [10] Beatrice Michael G, 2002, Pharm Biotechnol, V14, P405